Jonathan Gillis serves as Executive at MapLight Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Gillis has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 24,455 shares valued at $0.
Jonathan Gillis currently holds 24,455 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Gillis has been a net neutral trader of MPLT stock. They have purchased $0 and sold $0 worth of shares.
Jonathan Gillis's most recent insider trade was on Feb 5, 2026, when they sold 24,455 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2025 | MPLT | $0 | Award | 30,565 | $N/A | Discretionary |